Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97

Showing 26-50 of 97 citing articles:

Psychological booster shots targeting memory increase long-term resistance against misinformation
Rakoen Maertens, Jon Roozenbeek, Jon S. Simons, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects
Jiaqi Zhang, Shan Xing, Dan Liang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 33
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
Michael Müller, Johann Volzke, Behnam Subin, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
R. Medhat, Rania M. El-Lababidi, Manal Abdel-Salam, et al.
International Journal of Infectious Diseases (2022) Vol. 119, pp. 184-186
Open Access | Times Cited: 25
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells
Kilian A. Wietschel, Kevin Fechtner, Elmer Antileo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
Yana Debie, Timon Vandamme, Maria E. Goossens, et al.
European Journal of Cancer (2021) Vol. 163, pp. 177-179
Open Access | Times Cited: 31
Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation
Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
Giulio Disanto, Alice Galante, Marco Cantu', et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 20
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients
Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
Domenico Lo Tartaro, Annamaria Paolini, Marco Mattioli, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
State of the Art in Epitope Mapping and Opportunities in COVID-19
Samira M. Hamed, Masarra M. Sakr, Ghadir S. El-Housseiny, et al.
Future Science OA (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials
Hélène Bisceglia, Julie Barrier, Joseline Ruiz, et al.
Journal of Immunological Methods (2023) Vol. 515, pp. 113457-113457
Open Access | Times Cited: 11
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1706-1706
Open Access | Times Cited: 10
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose
Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1480-1480
Open Access | Times Cited: 24
Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination
Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 1, pp. 23-31
Open Access | Times Cited: 17
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
Elena Pettini, Annalisa Ciabattini, G Pastore, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2247-2249
Open Access | Times Cited: 15
A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
Joseph Torresi, Melissa A. Edeling, Terry Nolan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
COVID-19 vaccine boosters: What do we know so far?
Yousra Kherabi, Thibault Fiolet, Sacha Rozencwajg, et al.
Anaesthesia Critical Care & Pain Medicine (2021) Vol. 40, Iss. 6, pp. 100959-100959
Open Access | Times Cited: 19
Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 13
Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination
Ekaterina A. Astakhova, Maria G. Byazrova, Gaukhar M. Yusubalieva, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 1991-1991
Open Access | Times Cited: 13
New insights into human immune memory from SARS‐CoV‐2 infection and vaccination
Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3553-3566
Open Access | Times Cited: 12
Age, Sex and BMI Relations with Anti-SARS-CoV-2-Spike IgG Antibodies after BNT162b2 COVID-19 Vaccine in Health Care Workers in Northern Greece
Paraskevi Papaioannidou, Kalypso Skoumpa, Christos Bostanitis, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1279-1279
Open Access | Times Cited: 7

Scroll to top